Track the *ST美谷 share price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, *ST美谷 has published 9 reports. Market capitalisation: €6.2bn. The latest transaction was reported on 1 July 2022 (Sale). Among the most active insiders: 徐巍. The full history is accessible without an account.
9
Insider Decl.
0
Thresholds
·
7 ops.
Buy Volume
·
2 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 23,513 of 25,956 companies
21.3
score / 100
Value
30
Quality
13
FCF yld0.7%
Earn yld-7.9%
EV/EBITDA·
ROE-73%
Gross mgn23%
Net mgn-45%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.